Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000899902 | SCV001044192 | benign | not provided | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000899902 | SCV005305470 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001830962 | SCV002079306 | likely benign | Epidermolysis bullosa dystrophica | 2019-10-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003950542 | SCV004759157 | likely benign | COL7A1-related disorder | 2019-11-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |